These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3810829)

  • 1. A second Dr(a-) proposita with anti-Dra and a family with the Dr(a-) phenotype in two generations.
    Levene C; Harel N; Kende G; Papo S; Bradford MF; Daniels GL
    Transfusion; 1987; 27(1):64-5. PubMed ID: 3810829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family showing inheritance of the Inab phenotype.
    Lin RC; Herman J; Henry L; Daniels GL
    Transfusion; 1988; 28(5):427-9. PubMed ID: 3420669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent anti-Dra in two pregnancies.
    Rahimi-Levene N; Kornberg A; Siegel G; Morozov V; Shinar E; Asher O; Levene C; Yahalom V
    Immunohematology; 2005; 21(3):126-8. PubMed ID: 16178671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the blood of a Co (a-b-) proposita and her family.
    Lacey PA; Robinson J; Collins ML; Bailey DG; Evans CC; Moulds JJ; Daniels GL
    Transfusion; 1987; 27(3):268-71. PubMed ID: 3590290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A "new" phenotype confirming a relationship between Cra and Tca.
    Levene C; Harel N; Lavie G; Greenberg S; Laird-Fryer B; Daniels GL
    Transfusion; 1984; 24(1):13-5. PubMed ID: 6695433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.
    Lublin DM; Thompson ES; Green AM; Levene C; Telen MJ
    J Clin Invest; 1991 Jun; 87(6):1945-52. PubMed ID: 1710232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dr(a) (Cromer-related blood group antigen)-incompatible renal transplantation.
    Nakache R; Levene C; Sela R; Kaufman S; Shapira Z
    Vox Sang; 1998; 74(2):106-8. PubMed ID: 9501409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype.
    Wang L; Uchikawa M; Tsuneyama H; Tokunaga K; Tadokoro K; Juji T
    Blood; 1998 Jan; 91(2):680-4. PubMed ID: 9427725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UMC, another Cromer-related blood group antigen.
    Daniels GL; Okubo Y; Yamaguchi H; Seno T; Ikuta M
    Transfusion; 1989; 29(9):794-7. PubMed ID: 2480010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At(a-) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti-Ata.
    Sweeney JD; Holme S; McCall L; Huett D; Storry J; Reid M
    Transfusion; 1995 Jan; 35(1):63-7. PubMed ID: 7998074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible null phenotype in the Cromer blood group complex.
    Daniels GL; Tohyama H; Uchikawa M
    Transfusion; 1982; 22(5):362-3. PubMed ID: 7123631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I-i- phenotype in a large kindred Indian family.
    Joshi SR; Bhatia HM
    Vox Sang; 1984; 46(3):157-60. PubMed ID: 6710968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 'new' Cromer-related high frequency antigen probably antithetical to WES.
    Daniels GL; Green CA; Darr FW; Anderson H; Sistonen P
    Vox Sang; 1987; 53(4):235-8. PubMed ID: 3439100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of maternal antibody anti-Jra on the baby: a case report and pedigree chart.
    Takabayashi T; Murakami M; Yajima H; Tsujiei M; Ozawa N; Yajima A
    Tohoku J Exp Med; 1985 Jan; 145(1):97-101. PubMed ID: 3983961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P phenotype observed in two generations of Tunisian family with a high rate of inbreeding.
    Salmon D; Bouchmel S; Hafsia A; Boussen S; Boussen M; Bouguerra A
    Rev Fr Transfus Immunohematol; 1979 Dec; 22(5):563-71. PubMed ID: 547353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Gerbich antibodies and Gerbich-negative Dantu-positive red blood cells in a woman from South Africa.
    Moores P; de Beer R; Marais I; Levene C; May R; du Toit E
    Hum Hered; 1990; 40(4):242-6. PubMed ID: 2379930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection.
    Nowicki B; Truong L; Moulds J; Hull R
    Am J Pathol; 1988 Oct; 133(1):1-4. PubMed ID: 3052090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor.
    Daniels GL; Green CA; Powell RM; Ward T
    Transfusion; 1998 Apr; 38(4):332-6. PubMed ID: 9595014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel molecular basis of an Inab phenotype.
    Hue-Roye K; Powell VI; Patel G; Lane D; Maguire M; Chung A; Reid ME
    Immunohematology; 2005; 21(2):53-5. PubMed ID: 15954804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis.
    Cajander S; Tina E; Bäckman A; Magnuson A; Strålin K; Söderquist B; Källman J
    PLoS One; 2016; 11(5):e0154690. PubMed ID: 27144640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.